• Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W. (2002) Antiepileptic drug-induced bone loss in young male patients who have seizure. Arch Neurol 59:781786.
  • Beniczky SA, Viken J, Jensen LT, Andersen NB. (2012) Bone mineral density in adult patients treated with various antiepileptic drug. Seizure 21:471472.
  • El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. (2008) Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 43:149155.
  • Farhat G, Yamout B, Mikati MA, Demirjin S, Sawaya R, El-Hajj Fuleihan G. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:13481353.
  • Koo DL, Joo EY, Kim D, Hong SB. (2013) Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone mineral metabolism in patients with epilepsy. Epilepsy Res 104:134139.
  • Lee RH, Lyles KW, Sloane R, Colón-Emeric C. (2012) The association of newer anticonvulsant medication and bone mineral density. Endocr Pract 14:122; doi: 10.4158/EP12119.OR.
  • Nissen-Meyer LS, Svalheim S, Taubøll E, Reppe S, Lekva T, Solberg LB, Melhus G, Reinholt FP, Gjerstad L, Jemtland R. (2007) Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Epilepsia 48:18501860.
  • Phabphal K, Geater A, Leelawattana R, Satiraapanya P, Setthawatcharawanich S, Limapichart K. (2009) Prevalence and risk factors of low bone moneral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone 45:232237.
  • Stephen LJ, McLellan AR, Harrison JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ. (1999) Bone density and antiepileptic drugs: a case–controlled study. Seizure 8:339342.